The global cannabis pharmaceuticals market size is expected to reach USD 357.96 billion by 2034, according to a new study by Polaris Market Research. The report “Cannabis Pharmaceuticals Market Size, Share, Trends, Industry Analysis Report: By Brand Type (Sativex, Epidiolex, and Other Brands), Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The cannabis pharmaceuticals market demand is growing significantly, driven by increasing acceptance of cannabis-based treatments for medical conditions such as chronic pain, epilepsy, and anxiety. Expanding clinical evidence supporting the efficacy of cannabis, regulatory changes allowing greater access to medical cannabis, and rising patient demand for alternative therapies boost the market development. The cannabis pharmaceuticals market opportunities lie in the development of non-psychoactive products such as CBD, personalized treatments, and expanding into new markets as cannabis legalization increases globally.
Trends such as ongoing research into new medical applications, innovation in product formulations, and collaborations between pharmaceutical companies and cannabis producers are shaping the market. Overall, the market is poised for continued growth as more countries legalize cannabis and as medical professionals adopt cannabis-based therapies into treatment plans.
Cannabis Pharmaceuticals Market Report Highlights
Based on brand type, the Epidiolex segment dominates the cannabis pharmaceuticals market share due to its FDA approval for treating epilepsy and other neurological disorders.
The other brands segment is experiencing the highest growth, driven by increasing product development and approval of new cannabis-based therapies.
The online pharmacies segment, by distribution channel, holds the largest market share, driven by the convenience they offer to consumers and the increasing demand for cannabis-based medications.
North America is the dominant region, led by the US, where cannabis-based pharmaceuticals are gaining broad acceptance due to regulatory support and extensive clinical research. Asia Pacific region has the highest-growing market, with increasing legalization and rising demand for cannabis-based medical products, particularly in Australia and South Korea.
Polaris Market Research has segmented the cannabis pharmaceuticals market report on the basis of brand type, distribution channel, and region:
By Brand Type Outlook (Revenue – USD Billion, 2020–2034)
Sativex
Epidiolex
Other Brands
By Distribution Channel Outlook (Revenue – USD Billion, 2020–2034)
Online Pharmacies
Hospitals
Others
By Regional Outlook (Revenue – USD Billion, 2020–2034)
North America
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Cannabis Pharmaceuticals Market Insights
- 4.1. Cannabis Pharmaceuticals Market – Market Snapshot
- 4.2. Cannabis Pharmaceuticals Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Growing Adoption of Medical Cannabis
- 4.2.1.2. Expansion of Non-Psychoactive Cannabis Products
- 4.2.1.3. Increasing Investments and Research in Cannabis Medicine
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Stringent Regulatory Framework and High R&D Costs in the Cannabis Pharmaceuticals Market
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Cannabis Pharmaceuticals Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Cannabis Pharmaceuticals Market, by Brand Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 5.3. Sativex
- 5.3.1. Global Cannabis Pharmaceuticals Market, by Sativex, by Region, 2020-2034 (USD Billion)
- 5.4. Epidiolex
- 5.4.1. Global Cannabis Pharmaceuticals Market, by Epidiolex, by Region, 2020-2034 (USD Billion)
- 5.5. Other Brands
- 5.5.1. Global Cannabis Pharmaceuticals Market, by Other Brands, by Region, 2020-2034 (USD Billion)
- 6. Global Cannabis Pharmaceuticals Market, by Distribution Channel
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 6.3. Online Pharmacies
- 6.3.1. Global Cannabis Pharmaceuticals Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)
- 6.4. Hospitals
- 6.4.1. Global Cannabis Pharmaceuticals Market, by Hospitals, by Region, 2020-2034 (USD Billion)
- 6.5. Others
- 6.5.1. Global Cannabis Pharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)
- 7. Global Cannabis Pharmaceuticals Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Cannabis Pharmaceuticals Market Assessment, By Geography, 2020-2034 (USD Billion)
- 7.3. Cannabis Pharmaceuticals Market – North America
- 7.3.1. North America: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.3.2. North America: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.3.3. Cannabis Pharmaceuticals Market – U.S.
- 7.3.3.1. U.S.: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.3.3.2. U.S.: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.3.4. Cannabis Pharmaceuticals Market – Canada
- 7.3.4.1. Canada: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.3.4.2. Canada: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.4. Cannabis Pharmaceuticals Market – Europe
- 7.4.1. Europe: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.4.2. Europe: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.4.3. Cannabis Pharmaceuticals Market – UK
- 7.4.3.1. UK: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.4.3.2. UK: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.4.4. Cannabis Pharmaceuticals Market – France
- 7.4.4.1. France: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.4.4.2. France: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.4.5. Cannabis Pharmaceuticals Market – Germany
- 7.4.5.1. Germany: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.4.5.2. Germany: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.4.6. Cannabis Pharmaceuticals Market – Italy
- 7.4.6.1. Italy: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.4.6.2. Italy: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.4.7. Cannabis Pharmaceuticals Market – Spain
- 7.4.7.1. Spain: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.4.7.2. Spain: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.4.8. Cannabis Pharmaceuticals Market – Netherlands
- 7.4.8.1. Netherlands: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.4.8.2. Netherlands: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.4.9. Cannabis Pharmaceuticals Market – Russia
- 7.4.9.1. Russia: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.4.9.2. Russia: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.4.10. Cannabis Pharmaceuticals Market – Rest of Europe
- 7.4.10.1. Rest of Europe: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.4.10.2. Rest of Europe: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.5. Cannabis Pharmaceuticals Market – Asia Pacific
- 7.5.1. Asia Pacific: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.5.3. Cannabis Pharmaceuticals Market – China
- 7.5.3.1. China: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.5.3.2. China: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.5.4. Cannabis Pharmaceuticals Market – India
- 7.5.4.1. India: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.5.4.2. India: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.5.5. Cannabis Pharmaceuticals Market – Malaysia
- 7.5.5.1. Malaysia: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.5.5.2. Malaysia: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.5.6. Cannabis Pharmaceuticals Market – Japan
- 7.5.6.1. Japan: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.5.6.2. Japan: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.5.7. Cannabis Pharmaceuticals Market – Indonesia
- 7.5.7.1. Indonesia: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.5.7.2. Indonesia: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.5.8. Cannabis Pharmaceuticals Market – South Korea
- 7.5.8.1. South Korea: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.5.8.2. South Korea: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.5.9. Cannabis Pharmaceuticals Market – Australia
- 7.5.9.1. Australia: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.5.9.2. Australia: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.5.10. Cannabis Pharmaceuticals Market – Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.5.10.2. Rest of Asia Pacific: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.6. Cannabis Pharmaceuticals Market – Middle East & Africa
- 7.6.1. Middle East & Africa: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.6.3. Cannabis Pharmaceuticals Market – Saudi Arabia
- 7.6.3.1. Saudi Arabia: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.6.3.2. Saudi Arabia: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.6.4. Cannabis Pharmaceuticals Market – UAE
- 7.6.4.1. UAE: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.6.4.2. UAE: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.6.5. Cannabis Pharmaceuticals Market – Israel
- 7.6.5.1. Israel: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.6.5.2. Israel: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.6.6. Cannabis Pharmaceuticals Market – South Africa
- 7.6.6.1. South Africa: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.6.6.2. South Africa: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.6.7. Cannabis Pharmaceuticals Market – Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.6.7.2. Rest of Middle East & Africa: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.7. Cannabis Pharmaceuticals Market – Latin America
- 7.7.1. Latin America: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.7.3. Cannabis Pharmaceuticals Market – Mexico
- 7.7.3.1. Mexico: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.7.3.2. Mexico: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.7.4. Cannabis Pharmaceuticals Market – Brazil
- 7.7.4.1. Brazil: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.7.4.2. Brazil: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.7.5. Cannabis Pharmaceuticals Market – Argentina
- 7.7.5.1. Argentina: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.7.5.2. Argentina: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.7.6. Cannabis Pharmaceuticals Market – Rest of Latin America
- 7.7.6.1. Rest of Latin America: Cannabis Pharmaceuticals Market, by Brand Type, 2020-2034 (USD Billion)
- 7.7.6.2. Rest of Latin America: Cannabis Pharmaceuticals Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
- 9. Company Profiles
- 9.1. GW Pharmaceuticals (now part of Jazz Pharmaceuticals)
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Tilray
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Canopy Growth
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Aurora Cannabis
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Organigram
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Altria Group (parent company of Cronos Group)
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Zynerba Pharmaceuticals
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. MedReleaf
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Green Thumb Industries
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Aphria (now part of Tilray)
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Hexo Corporation
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook